Xenon Pharmaceuticals Inc. 4

Steven Gannon sold 10,000 Xenon Pharmaceuticals Inc. (XENE) common shares at a weighted-average price of about $64.06 on 2026-08-11.

On 2026-08-11, insider Steven Gannon sold 10,000 common shares of Xenon Pharmaceuticals Inc. in an open-market transaction at a weighted-average price of approximately $64.055 per share, for total proceeds of about $640,550. The sale was executed in multiple trades within a narrow price range of $64.0517 to $64.078 per share, and following this disposition, Gannon’s direct ownership in Xenon Pharmaceuticals stands at 1,870 common shares. The transaction was reported on Form 4 filed on 2026-08-13, with the filer represented by attorney-in-fact Nathaniel Adams.

Filing Facts

CIK

1582313

Ticker

XENE

Form

4

Source Type

fda

Accession

0001193125-26-349351

Alert Tier

6